Innate immunity in COVID-19 patients mediated by NKG2A receptors, and potential treatment using Monalizumab, Cholroquine, and antiviral agents

Following the outbreak of a novel coronavirus (SARS-CoV-2), studies suggest that the resultant disease (COVID-19) is more severe in individuals with a weakened immune system. Cytotoxic T-cells (CTLs) and Natural Killer (NK) cells are required to generate an effective immune response against viruses,...

Descripción completa

Detalles Bibliográficos
Autores principales: Yaqinuddin, Ahmed, Kashir, Junaid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194824/
https://www.ncbi.nlm.nih.gov/pubmed/32344314
http://dx.doi.org/10.1016/j.mehy.2020.109777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194824/
https://www.ncbi.nlm.nih.gov/pubmed/32344314
http://dx.doi.org/10.1016/j.mehy.2020.109777

Ejemplares similares